June 26, 2019
Amsterdam, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today announced that it has completed the cancellation of 30,000,000 of its shares. The cancelled shares were acquired as part of Philips’ recently completed EUR 1.5 billion share repurchase program that started in the third quarter of 2017, and of Philips’ ongoing EUR 1.5 billion share repurchase program that started in the first quarter of 2019. Further details on the repurchase program can be found here.
Philips’ current issued share capital amounts to EUR 181,055,015.40, representing 905,275,077 common shares.
For further information, please contact:
Philips Group Press Office
Tel.: +31 6 1521 3446
Philips Investor Relations
Tel.: +31 20 5977055
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2018 sales of EUR 18.1 billion and employs approximately 77,000 employees with sales and services in more than 100 countries. News about Philips can be found at http://www.philips.com/